Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ118511870,59
KB10571059-0,56
PKN72,6372,650,21
Msft446,75447,5-0,50
Nokia4,6254,629-0,69
IBM252,88253,9-0,22
Mercedes-Benz Group AG53,5153,521,25
PFE22,9222,94-0,61
13.05.2025 13:05:51
Indexy online
AD Index online
select
AD Index online
 

  • 23.04.2025 17:47:07
Gentex Corp (GNTX.F, Frankfurt)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
19,20 5,53 1,10 9 811
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 13.05.2025
Popis společnosti

Business Summary: Gentex Corporation is a supplier of digital vision, connected car, dimmable glass, fire protection technologies and consumer electronics. The Company's segments include Automotive Products and Other. The Automotive Products segment designs, develops, manufactures and markets interior and exterior automatic-dimming automotive rearview mirrors that utilize proprietary electrochromic technology to dim in proportion to the amount of headlight glare from trailing vehicle headlamps. Within this segment, it also designs, develops and manufactures various electronics that are value added features to the interior and exterior automotive rearview mirrors as well as electronics for interior visors, overhead consoles, and other locations in the vehicle. The Other segment includes Fire Protection, Dimmable Aircraft Windows, Nanofiber, Medical, and Biometrics. It manufactures photoelectric smoke detectors and alarms, visual signaling alarms, audible and visual signaling appliances, and others.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Gentex Corp revenues decreased 2% to $576.8M. Net income applicable to common stockholders decreased 12% to $93.5M. Revenues reflect Automotive Products segment decrease of 2% to $563.9M, Other segment decrease of 8% to $11.6M, South Korea (Country) segment decrease of 29% to $38.2M, Germany segment decrease of 14% to $65M, China segment decrease of 14% to $41M.



  • Poslední aktualizace: 13.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorChristopher Viehbacher6414.11.202214.11.2022
Chief Financial Officer, Executive Vice PresidentRobin Kramer5901.03.202519.11.2018
Chief Human Resource Officer, Executive Vice PresidentGinger Gregory5617.07.201717.07.2017
Executive Vice President, Chief Legal OfficerSusan Alexander6730.01.2006
Executive Vice President, Head of ResearchJane Grogan57
Executive Vice President, Head of Global Product Strategy and CommercializationRachid Izzar49
Executive Vice President, Head of Corporate DevelopmentAdam Keeney4817.04.202317.04.2023
Executive Vice President - Pharmaceutical Operations and TechnologyNicole Murphy51
Executive Vice President, Head of DevelopmentPriya Singhal5605.01.202305.01.2023
Chief Accounting Officer, Vice President, Global Corporate Controller, Principal Accounting OfficerSean Godbout5001.03.202501.03.2025